Pharmacokinetics of bendazac lysine in 10 Chinese young men

Acta Pharmacologica Sinica

Volumn 18, Issue 2, 1997, Pages 109-111

  Chen, Xiao Xiang ^a   Zhang, Yin Di ^a   Shen, Jian Ping ^a   Pu, Jun ^a   Yan, Han Ying ^b   Zhu, Yan Qing ^b   Qiu, Jian Jin ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Institute of Materia Medica   (China)

Author keywords

bendazac; high pressure liquid chromatography; lysine; pharmacokinetics

Indexed keywords

BENDAZAC LYSINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CHINESE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MICROCOMPUTER; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TABLET; ULTRAVIOLET SPECTROPHOTOMETRY; VOLUNTEER;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; HUMANS; INDAZOLES; MALE; THERAPEUTIC EQUIVALENCY;

EID: 0030931238     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Balfour JA, Clissold SP. Bendazac Lysine-A review of its pharmacological properties and therapeutic potential in the management of cataracts. Drugs 1990; 39: 575-96.
2. Sater R, Steinijans VW, Diletti E, Bohm A, Schulz HU. Presentation of results from bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 1992; 30 Suppl 1: s7-s30.
3. Huang SK, Han KQ. Several analysis methods of bioequivalence assessments. Chin J Clin Pharmacol 1993; 9: 43-6.
4. Valeri P, Palmery M, Tita B, Silvestrinl B. Investigations on the ocular pharmacokinetics of Bendazac in rabbits. Exp Mol Pathol 1985; 43: 283-7.
5. Yan HY, Zhen YL. Macropopous resin and its application in the pharmacokinetic study. Pharm Ind 1981; 1: 22-7.